Clinicopathologic significance of immunostaining of α-thalassemia/ mental retardation syndrome X-linked protein and death domain-associated protein in neuroendocrine tumors

Human Pathology

Volumn 44, Issue 10, 2013, Pages 2199-2203

  Chen, Shi Fan ^a,b   Kasajima, Atsuko ^a   Yazdani, Samaneh ^c   Chan, Monica S M ^c,d   Wang, Lin ^e   He, Yang Yang ^b   Gao, Hong Wen ^b   Sasano, Hironobu ^c  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIMED Medical Institute   (Hong Kong)

^e HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

ATRX; DAXX; Neuroendocrine tumors

Indexed keywords

ALPHA THALASSEMIA MENTAL RETARDATION SYNDROME X LINKED PROTEIN; DAXX PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JAPANESE; LARGE CELL NEUROENDOCRINE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PANCREAS ADENOCARCINOMA; PANCREAS ISLET CELL; PANCREATIC NEUROENDOCRINE TUMOR; PROTEIN EXPRESSION; SCHOOL CHILD; TUMOR CELL;

ATRX; DAXX; NEUROENDOCRINE TUMORS;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-THALASSEMIA; CHILD; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MENTAL RETARDATION, X-LINKED; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREAS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84884411755     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.04.025     Document Type: Article

References (19)

1. E.S. Chan, J. Alexander, P.E. Swanson, D. Jain, and M.M. Yeh PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms Am J Surg Pathol 36 2012 737 743
2. I.M. Modlin, K.D. Lye, and M.A. Kidd 5-Decade analysis of 13,715 carcinoid tumors Cancer 97 2003 934 959
3. R.N. Yunes Neuroendocrine tumors: a registry of 1,000 patients Rev Assoc Med Bras 54 2008 305 307
4. O. Hauso, B.I. Gustafsson, and M. Kidd Neuroendocrine tumor epidemiology: contrasting Norway and North America Cancer 113 2008 2655 2664
5. T. Ito, H. Sasano, and M. Tanaka Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan J Gastroenterol 45 2010 234 243
6. A. Kasajima, M. Pavel, and S. Darb-Esfahani mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours Endocr Relat Cancer 18 2011 181 192
7. Y. Jiao, C. Shi, and B.H. Edil DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors Science 331 2011 1199 1203
8. J. Tang, S. Wu, and H. Liu A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein J Biol Chem 279 2004 20369 20377
9. R.J. Gibbons, D.J. Picketts, L. Villard, and D.R. Higgs Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome) Cell 80 1995 837 845
10. D.J. Picketts, D.R. Higgs, S. Bachoo, D.J. Blake, O.W. Quarrell, and R.J. Gibbons ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome Hum Mol Genet 5 1996 1899 1907
11. Y. Xue, R. Gibbons, and Z. Yan The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies Proc Natl Acad Sci USA 100 2003 10635 10640
12. X. Nan, J. Hou, and A. Maclean Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation Proc Natl Acad Sci USA 104 2007 2709 2714
13. F.T. Bosman, F. Carneiro, and R.H. Hruban WHO Classification of Tumours of the Digestive System 2010 IARC Lyon
14. S. Yachida, E. Vakiani, and C.M. White Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors Am J Surg Pathol 36 2012 173 184
15. E.M. Je, C.H. An, and N.J. Yoo Expressional and mutational analysis of ATRX gene in gastric, colorectal and prostate cancers APMIS 120 2012 519 520
16. C.M. Heaphy, R.F. de Wilde, and Y. Jiao Altered telomeres in tumors with ATRX and DAXX mutations Science 33 2011 425
17. R.F. de Wilde, C.M. Heaphy, and A. Maitra Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors Mod Pathol 25 2012 1033 1039
18. C.A. Lovejoy, W. Li, and S. Reisenweber Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway PLoS Genet 8 2012 e1002772
19. K.L. McDonald, J. McDonnell, and A. Muntoni Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival J Neuropathol Exp Neurol 69 2010 729 736